Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartomeu Massutí

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 7, 2025
Letter to Editor-in-ChiefMariano Provencio, Bartomeu Massutí, Florentino Hernando-Trancho
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|May 4, 2021
Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancerAmparo Burgos-San José, Claudia Colomer-Aguilar, Daniel Martínez-Caballero, et al.
Clinical Lung Cancer|May 16, 2009
Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapyPilar Garrido, Rafael Rosell, Bartomeu Massutí, et al.
Anti-Cancer Drugs|May 29, 2004
Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumorsAlbert Abad, Bartomeu Massutí, Javier Gallego, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodologySusana Benlloch, Artemio Payá, Cristina Alenda, et al.
Cancer|September 20, 2006
Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusionSusana Benlloch, Jose Marcelo Galbis-Caravajal, Concepcion Martín, et al.
Clinical Lung Cancer|October 10, 2006
Cell-free DNA concentration in pleural fluid and serum: quantitative approach and potential prognostic factor in patients with cancer and pleural effusionsSusana Benlloch, Juan Luis Martí-Ciriquián, José Marcelo Galbis-Caravajal, et al.
Thoracic Cancer|September 28, 2020
Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER databaseBegoña Campos-Balea, Javier de Castro Carpeño, Bartomeu Massutí, et al.
Clinical Colorectal Cancer|September 10, 2013
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumabJavier Sastre, Marta Vidaurreta, Auxiliadora Gómez, et al.
Gaceta Sanitaria|May 31, 2022
[Representativeness of the Spanish Thoracic Tumour Registry. Comparison of sociodemographic data with other national registries]Cristina Candal-Pedreira, Alberto Ruano-Ravina, Enric Carcereny, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|February 7, 2025
Letter to Editor-in-ChiefMariano Provencio, Bartomeu Massutí, Florentino Hernando-Trancho
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|May 4, 2021
Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancerAmparo Burgos-San José, Claudia Colomer-Aguilar, Daniel Martínez-Caballero, et al.
Clinical Lung Cancer|May 16, 2009
Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapyPilar Garrido, Rafael Rosell, Bartomeu Massutí, et al.
Anti-Cancer Drugs|May 29, 2004
Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumorsAlbert Abad, Bartomeu Massutí, Javier Gallego, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodologySusana Benlloch, Artemio Payá, Cristina Alenda, et al.
Cancer|September 20, 2006
Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusionSusana Benlloch, Jose Marcelo Galbis-Caravajal, Concepcion Martín, et al.
Clinical Lung Cancer|October 10, 2006
Cell-free DNA concentration in pleural fluid and serum: quantitative approach and potential prognostic factor in patients with cancer and pleural effusionsSusana Benlloch, Juan Luis Martí-Ciriquián, José Marcelo Galbis-Caravajal, et al.
Thoracic Cancer|September 28, 2020
Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER databaseBegoña Campos-Balea, Javier de Castro Carpeño, Bartomeu Massutí, et al.
Clinical Colorectal Cancer|September 10, 2013
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumabJavier Sastre, Marta Vidaurreta, Auxiliadora Gómez, et al.
Gaceta Sanitaria|May 31, 2022
[Representativeness of the Spanish Thoracic Tumour Registry. Comparison of sociodemographic data with other national registries]Cristina Candal-Pedreira, Alberto Ruano-Ravina, Enric Carcereny, et al.
Pageof 7